Related Experiment Video
Updated: Jun 23, 2025

06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.3K
Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept
Emily W Paolillo1, Kaitlin B Casaletto1, Annie L Clark1
1Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.
JMIR Aging
|June 26, 2024
Summary
Smartphone battery use can indicate frontotemporal lobar degeneration (FTLD) severity. Reduced daily smartphone activity in FTLD patients suggests a potential digital biomarker for monitoring disease progression.
Area of Science:
- Neuroscience
- Digital Health
- Gerontology
Background:
- Frontotemporal lobar degeneration (FTLD) is a primary cause of dementia in individuals under 65.
- In-person assessments for FTLD present challenges, highlighting the need for remote, accessible monitoring tools.
- Previous studies show reduced computer use correlates with cognitive decline, but smartphone use associations are unclear.
Purpose of the Study:
- To analyze daily smartphone battery usage patterns as a proxy for smartphone activity in FTLD patients.
- To investigate the correlation between smartphone usage patterns and clinical indicators of FTLD severity.
Main Methods:
- 231 adults (including clinically normal, prodromal FTLD, and symptomatic FTLD) had the ALLFTD Mobile App installed on their smartphones.
- Passive, continuous monitoring of smartphone battery percentage was collected every 15 minutes over an average of 28 days.
- Linear mixed-effects models analyzed temporal battery percentage variations against clinical severity measures (CDR+NACC FTLD, cognitive tests, neuropsychiatric inventory, MRI volumes), controlling for covariates.
Main Results:
- Participants with prodromal or symptomatic FTLD showed significantly less daily fluctuation in battery percentage, indicating reduced smartphone use compared to controls (P<.001).
- Worse performance in cognitive domains (executive function, memory, language, visuospatial skills), increased neuropsychiatric symptoms, and smaller brain volumes were all associated with decreased daily battery use (P<.001).
- CDR+NACC FTLD global scores interacted with time of day, confirming reduced daily smartphone activity in FTLD groups.
Conclusions:
- Passively collected smartphone usage data, reflected in battery drain patterns, is a viable digital marker associated with clinical impairment in FTLD.
- This study provides proof of concept for using smartphone behavior as a remote monitoring tool for neurodegenerative diseases.
- Future research should focus on validating passive digital markers for tracking longitudinal neurobehavioral changes in FTLD and other neurodegenerative conditions.
Related Concept Videos
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461

